Alphatec Holdings (ATEC) stock plummeted 5.06% in the pre-market trading session on Thursday, following the company's fourth-quarter 2024 earnings call where it provided guidance for the upcoming year.
During the earnings call, Alphatec projected revenue growth of 20% for 2025, which came in lower than analysts' expectations. The company forecasted revenue of approximately $732 million for the year, including surgical revenue growth of 21% to around $657 million.
While Alphatec reported strong fourth-quarter results, with revenue growing 28% year-over-year and adjusted EBITDA reaching $21 million, investors seemed concerned about the company's outlook for the coming year. The projected revenue growth rate of 20% was viewed as disappointing, especially in light of the company's recent performance and the disruptions in the spine surgery market.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.